Xeris Biopharma (XERS) Market Performance – 22 April 2026
- Price movement – Xeris Biopharma shares increased 1.64 % during the 24‑hour period ending at 02:45 AM Central European Time on Thursday 22 April 2026.
- Current price – As of the latest trade, one share trades at approximately USD 10.78 on major exchanges.
- Trading volume – In the preceding 24 hours, approximately USD 32.3 million worth of XERS shares were traded.
- Share supply – The total number of shares outstanding is 182.6 million.
- Market capitalisation – The company’s market value stands at USD 2 billion.
- Year‑to‑date performance – Since the close of the previous month, XERS shares have risen 26.48 %.
- Technical indicators – The simple moving average over the last 200 days is USD 7.38.
- 52‑week range – The highest price reached in the last 52 weeks was USD 11.42 on 19 October 2026; the lowest price was USD 5.25 on 25 March 2026.
Recent performance of related stocks
| Ticker | 24‑hour change | Current price (USD) | Market capitalisation (USD) | P/E ratio (Lincoln only) |
|---|---|---|---|---|
| LCLN | +3.78 % | 24.00 | 2.4 billion | 5.83 |
| VRDN | +7.84 % | 23.01 | 2.4 billion | – |
| PGEN | +2.55 % | 6.60 | 2.4 billion | – |
| NWL | +2.53 % | 5.56 | 2.4 billion | – |
| CLOV | +8.11 % | 4.78 | 2.4 billion | – |
Company overview
Xeris Biopharma Holdings, Inc. is a holding entity that provides novel formulation‑technology platforms for developing and commercializing ready‑to‑use, liquid‑stable injectables. Through its subsidiaries, the company delivers these innovative solutions to customers worldwide within the health‑care sector.
